Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Eat Well for Heart Failure

Official title: Eat Well Produce Prescription for Duke Health Patients With Congestive Heart Failure

Run by Duke University · NCT07101289 · Data updated 2026-11-12

This trial tests whether providing produce prescriptions plus different levels of nutritional coaching helps Duke Health patients with congestive heart failure stay healthier and use less health care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment900 (estimated)
SponsorDuke University
Academic / other
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedOctober 22, 2025
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedNovember 12, 2025
Trial IDNCT07101289 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with a diagnosis of congestive heart failure who had a hospitalization or emergency visit in the past 12 months and are at risk of food insecurity or are Medicaid/dual eligible, who prefer English, have a valid email, and an NC mailing address.

Probably not a fit

Patients receiving dialysis or with end-stage renal disease, those with an LVAD or heart transplant, people unable to participate in English or without a North Carolina mailing address or email are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a pragmatic, parallel three-arm randomized trial conducted at Duke Health that compares a produce prescription program delivered with minimal behavioral support, the same program with intensified behavioral support, and usual care. Interventions include prescription produce distributions and personal health planning with virtual nutritional coaching. Participants are adults with congestive heart failure who had a hospitalization or ED visit in the past 12 months and are at risk of food insecurity or are Medicaid/dual eligible. Outcomes include patient health measures, health care utilization and costs, and identification of barriers and facilitators to implementing the program.

Why it matters

Potential benefit: If successful, the program could improve nutrition, reduce hospital readmissions, and lower health care costs for patients with heart failure.

How similar studies have gone: Other 'Food is Medicine' produce prescription programs have improved diet and food security in prior studies, but evidence specifically showing improved heart failure outcomes is limited, so this application to CHF is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 or older
* Diagnosis of CHF regardless of ejection fraction AND
* Hospitalization or ED visit within the past 12 months AND
* At risk of food insecurity as defined by one of the following:

screened positive for financial instability (medium risk and up) or food insecurity in the past 12 months minimum OR a Medicaid or dual eligible enrollee

* English as preferred language
* Valid email address (for virtual health coaching intervention)
* NC mailing address

Exclusion Criteria:

* History of dialysis or end stage renal disease OR
* History of LVAD or heart transplant.

Where it's running

  • Duke Health
    Durham, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.